Halozyme Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. 

CEO
Helen I. Torley
CEOHelen I. Torley
Employees
350
Employees350
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
350
Employees350

HALO Key Statistics

Market cap
8.03B
Market cap8.03B
Price-Earnings ratio
18.99
Price-Earnings ratio18.99
Dividend yield
—
Dividend yield—
Average volume
1.67M
Average volume1.67M
High today
$65.21
High today$65.21
Low today
$63.50
Low today$63.50
Open price
$64.10
Open price$64.10
Volume
4.00M
Volume4.00M
52 Week high
$65.53
52 Week high$65.53
52 Week low
$37.73
52 Week low$37.73

Analyst ratings

50%

of 10 ratings
Buy
50%
Hold
50%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.